- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03045601
Diagnostic Accuracy of CT-FFR Compared to Invasive Coronar Angiography With Fractional Flow Reserve
March 8, 2021 updated by: St. Olavs Hospital
Diagnostic Accuracy of Coronary Computed Tomographic Angiography Derived Fractional Flow Reserve Compared to Invasive Coronar Angiography With Fractional Flow Reserve
Invasive coronary angiography is currently considered gold standard in the assessment of coronary artery disease although the method has limitations.
Most importantly invasive angiography only depicts coronary anatomy without determining its physiological significance i.e the likelihood that the stenosis impedes oxygen delivery to the heart muscle.
Fractional flow reserve (FFR) is a catheterization technique for assessing the physiological significance of a coronary artery lesion during invasive coronary angiography.
Coronary computed tomographic angiography (CCTA) is a noninvasive imaging test that has become an alternative route to diagnosis for patients with suspected coronary artery disease.
Computational fluid dynamics combined with anatomical models based on CCTA scans allows determination of coronary flow and pressure, and has emerged as a promising diagnostic modality called CT-FFR.
In this Project New Mathematical algorithms are developed for computation of CT-FFR.
The main objective of this study is to determine the diagnostic accuracy of CT-FFR values obtained by the new method compared with invasive coronary angiography with fractional flow reserve and state-of-the-art dobutamin stress echocardiography.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
182
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway
- St Olavs Hospital, Klinikk for hjertemedisin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria
- Proven stenosis by CCTA that require further investigation with invasive coronary angiography i.e. patients with estimated stenosis ≥30- 50%.
- Informed consent
Exclusion Criteria:
- Patients with unstable coronary artery disease.
- Previously treated with PCI or coronary surgery.
- Severe renal impairment i.e. GFR <30ml / min
- Contrast allergy
- Contraindication to adenosine / nitroglycerin / beta-blocker
- BMI> 40
- Patients referred on the basis of technically unsuccessful CTA, motion artifact or similar
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CT-FFR
Analyse With New CT-FFR Method
|
Invasive FFR and CCTA With CT-FFR
|
|
Active Comparator: Stress echocardiography
Analyse With invasive FFR and stress echocardiography
|
Stress echocardiography and invasive FFR
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CT- FFR values by New Method as a dichotomous variable
Time Frame: 4 weeks
|
Determining the diagnostic accuracy of CT-FFR values obtained by the new method compared with invasive coronary angiography with fractional flow reserve
|
4 weeks
|
|
Worsening regional wall motion abnormality
Time Frame: 4 weeks
|
Determining the diagnostic accuracy of invasive FFR with comprehensive stress echocardiographic techniques
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Petter Aadahl, MD, PhD, Norwegian University of Science and Technology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 21, 2017
Primary Completion (Actual)
March 1, 2021
Study Completion (Actual)
March 1, 2021
Study Registration Dates
First Submitted
January 26, 2017
First Submitted That Met QC Criteria
February 3, 2017
First Posted (Estimate)
February 7, 2017
Study Record Updates
Last Update Posted (Actual)
March 9, 2021
Last Update Submitted That Met QC Criteria
March 8, 2021
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/1609
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Disease
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Stenosis | Coronary Restenosis | Coronary Artery Disease Progression | Coronary Stent Occlusion | Myocardial Revascularization
-
SUK MIN SEODaewoong Pharmaceutical Co. LTD.RecruitingCoronary Artery Disease (CAD) | Acute Coronary Syndromes (ACS)South Korea
-
Olivier F. BertrandRecruitingBifurcation Coronary Disease | Restenosis, Coronary | Coronary Arterial Disease (CAD)Canada
-
Ceric SàrlEuropean Cardiovascular Research Center; Philips Medical SystemsNot yet recruitingStable Coronary Artery Disease | Acute Coronary Syndromes
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationSouth Korea
-
Cardiocentro TicinoNot yet recruitingMultivessel Coronary Artery Disease | Coronary Vessel | Acute Coronary Syndromes (ACS) | Vulnerable Coronary Plaques | Coronary Arterial Disease (CAD)Switzerland
Clinical Trials on CT-FFR
-
Northwell HealthToshiba America Medical Systems, Inc.Enrolling by invitationCoronary Artery Disease | Chest Pain | Acute Coronary Syndrome | Acute Myocardial InfarctionUnited States
-
Northwell HealthHeartFlow, Inc.CompletedAngina, Stable Chest Pain
-
Toshiba Medical Systems Corporation, JapanCompleted
-
St. Antonius HospitalUMC Utrecht; ZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingCoronary Artery DiseaseNetherlands
-
HeartFlow, Inc.TerminatedCoronary Artery DiseaseUnited States
-
Beijing HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking...Recruiting
-
Stanford UniversitySiemens Medical SolutionsTerminatedCoronary Artery Disease | Computed TomographyUnited States
-
Seoul National University HospitalSeverance Hospital; Keimyung University Dongsan Medical Center; Chosun University... and other collaboratorsCompletedCoronary Artery DiseaseKorea, Republic of
-
Chinese PLA General HospitalTongji Hospital; Qilu Hospital of Shandong University; Second Affiliated Hospital... and other collaboratorsCompletedCoronary Artery DiseaseChina
-
Rigshospitalet, DenmarkRecruitingCardiovascular Diseases | Coronary Artery Disease | Heart Failure | Stroke | Acute Myocardial Infarction | Chest SyndromeDenmark